Immunoassays – News and Features
News
Tepnel Provides Update on Development of Contract Analysis Facility
Tepnel purchases land in Livingston, Scotland for the construction of a pharmaceutical, protein and genomic analysis facility.
News
Applied Biosystems/MDS Sciex Mass Spectrometer Cuts Costs for Therapeutic Drug Monitoring
Researchers says, using LC/MS/MS, they can simultaneously determine several compounds.
News
CST Announces Expansion of Studies with AstraZeneca
Studies will be performed with CST's PhosphoScan™ technology to identify phosphorylation profiles of kinase targeted lead compounds.
News
Gentel Biosurfaces Changes Name to Gentel Biosciences
The name change reflects company’s growth into an integrated, full-service multiplex immunoassay company.
News
Charles River Laboratories Signs Licensing Agreement with Luminex
Charles River will utilize Luminex's xMAP® technology within Charles River's Research Models and Services business segment.
News
Patient Outcomes Linked to Biomarker Levels by Quantitative Technology
AQUA has proven to be an effective tool in determining the flaws and inconsistencies associated with immunohistochemistry.
News
LifeSpan Announces Agreement with Pfizer
Pfizer will gain access to all the features of the LifeSpan’ DrugTarget Database™.
News
Nanosphere Awarded U.S. Patent for Biobarcode™ Protein Detection Technology
Biobarcode™ technology is designed for protein detection, for nucleic acid detection and genomics.
News
Compugen Announces Organizational Changes and Restructuring
Three units formed to support recently announced development and commercialization plans.
News
Fisher Adds GenTel® Thin-Film Nitrocellulose Slides to Its Portfolio
GenTel slides are designed for protein-array applications, including the profiling of disease biomarkers.
Advertisement
